Researchers successfully incorporated BPC-157 into a chitosan-based hydrogel matrix, achieving 98.9% encapsulation with 81.2% release within 24 hours. The composite demonstrated strong antibacterial properties against E. coli and S. aureus, good biocompatibility, and injectability—suggesting practical delivery advantages for practitioners. This advancement demonstrates viable formulation strategies for peptide stability and bioavailability, relevant to oral and topical delivery optimization.
For your business
Chitosan hydrogel achieved 98.9% BPC-157 encapsulation with 81.2% release in 24h, supporting topical or injectable delivery formulation discussions.